Home › Funds › Propel Bio Management, LLC › IMUX

Propel Bio Management, LLC position in IMUX

IMMUNIC INC · Health Care

Propel Bio Management, LLC reported holding 236,734 shares of IMUX (IMMUNIC INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 1.17% of its reported portfolio and ranking #25 among its reported holdings. Propel Bio Management, LLC has disclosed IMUX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)236.73K sh
Reported value held$2.20M
Portfolio Weight1.17%
First reportedQ1 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's IMUX position evolved

Propel Bio Management, LLC first disclosed a stake in IMUX in Q1 2026 at 2,344,779 shares (US$2.6M). The position peaked in Q2 2026 at 325,022 shares, worth US$5.0M. Across 3 filings, Propel Bio Management, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 236,734 shares valued at US$2.2M — a reduction of -88,288 shares quarter over quarter.. Notable position changes include a 86% trim in Q2 2026 (shares fell 39% over the following quarter), a 27% trim in Q3 2026 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 2.34M $2.62M New
Q2 2026 325.02K $5.00M Reduce
Q3 2026 236.73K $2.20M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMUX and 13F data

IMUX (IMMUNIC INC) is a Health Care company. 35 other funds we track also report a position in IMUX — the largest reported positions include BVF INC/IL (US$11.8M), Avidity Partners Management LP (US$10.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMUX

All IMUX fund holders →

FAQ

How long has Propel Bio Management, LLC held IMUX?

Propel Bio Management, LLC has disclosed IMUX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Propel Bio Management, LLC's current position in IMUX?

As of Q3 2026, Propel Bio Management, LLC holds 236.73K shares of IMUX (IMMUNIC INC), valued at $2.20M, representing 1.17% of its reported portfolio and ranking #25.

Has Propel Bio Management, LLC been buying or selling IMUX?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in IMUX. The position peaked in Q2 2026 at 325.02K shares.

Which other funds hold IMUX?

Other major institutional holders of IMUX include BVF INC/IL, Avidity Partners Management LP, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.